Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Personalised Medicine 2015

Personalised Medicine 2015

Date: Tuesday, 12 May 2015 - Wednesday, 13 May 2015
Location: Cambridge

Keynote Speakers

Carlos Caldas

Carlos Caldas
Group Leader, Cancer Research UK, Cambridge Institute

Mark Caulfield

Mark Caulfield
Chief Scientist, Queen Mary University of London

Nitzan Rosenfeld

Nitzan Rosenfeld
Senior Group Leader, Cancer Research UK and CSO, Inivata Ltd.


SELECTBIO is pleased to announce that we will be hosting a workshop on Personalised Medicine from 12th-13th May 2015 at Buckingham House, Murray Edwards College in Cambridge, UK.  For those unable to attend the live event, talks will also be streamed live with the facility to interact via our online Q&A system.

Click here
to register for the hybrid event at a  nominal service charge of just £99 + tax (£118.80 total).

With the onset of the genomic era and increase in clinical molecular analysis, more and more, clinicians and researchers are clearly defining multiple disease subtypes for diseases that were once thought to be singular in cause. This is opening the door to the discovery and development of highly effective and targeted diagnostics and therapies that result in better patient outcomes and the reduction in use of generalised treatments with severe side effects. Despite these benefits the regulatory and financial systems are not yet in place to enable this revolution in healthcare to flourish and there are many hurdles to overcome before personalized medicine can become commonplace. 

At Personalised Medicine 2015, you will benefit from the expert knowledge of leaders into omics and disease research who are currently working towards a future where medical interventions are more precise, more targeted and are resulting in better patient outcomes. You will hear from those that are currently discovering and developing therapies, with companion diagnostics, and from the professionals who are responsible for personalised medical products that have already hit the market. There will also be discussions involving industry and regulatory bodies on the improvements and challenges of personalized medicine and its practical impact on the future of healthcare.

Agenda Topics

  • Diagnostics Regulatory Updates
  • Imaging Based Diagnostics
  • Intellectual Property, Reimbursement & HTA Focus
  • NGS-Based Diagnostics
  • Personalised Breast Cancer Medicine
  • Whole Genome Sequencing, The 100,000 Project

Sponsorship and Exhibition Opportunities

Exhibition Team,
+44 (0) 1206 501654

Confirmed Speakers to date

James Brenton, Senior Group Leader, Cancer Research UK
Charles Cox, Head Genetics Experiment Design and Delivery, GSK Pharmaceuticals
Jurgen Eils, Head, German Cancer Research Centre
Thomas Krahn, Head of Global Biomarker Research Department, Bayer Pharma Ag
Claudia Meinken, European Patent Attorney, Patents and Trademarks for Life Sciences
Iain Miller, Co-Founder, Healthcare Strategies Group
Scott Palmer, Vice President , Ernst & Young LLP
Rosalind Polley, Senior Medical Device Specialist, Medicines & Healthcare Products Regulatory Agency (MHRA)
Kristin Ciriello Pothier, Partner & Managing Director/Life Sciences Leader, Ernst and Young LLP
Cecilia Schott, Head Personalized Healthcare, Corporate Business Development Global Product & Portfolio Strategy, AstraZeneca
Andreas Schuppert, Vice President, Bayer Technology Services GmbH
Christoph Turck, Head, Max Planck Institute of Psychiatry

Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks

Add to Calendar ▼2015-05-12 00:00:002015-05-13 00:00:00Europe/LondonPersonalised Medicine 2015Personalised Medicine 2015 in